Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis
Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Background
Treatment of post-transplant focal segmental glomerulosclerosis (FSGS) recurrence is still debated. The use of the fully human anti-CD20 monoclonal antibody ofatumumab has been suggested.
Case-diagnosis/treatment
Two boys with FSGS received a kidney transplantation at the age of 15 years from a deceased and a living donor. Maint...
Alternative Titles
Full title
Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2331783540
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2331783540
Other Identifiers
ISSN
0931-041X
E-ISSN
1432-198X
DOI
10.1007/s00467-019-04365-w
